Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > GBA(Gene name) > Human
  • Add your favorite
  • GBA (Gene name),
  • Glucosylceramidase (Protein name ),  GLCM_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    GBA(GC;GLUC);
    Protein name:
    Glucosylceramidase;
    Alternative:
    Alglucerase;Acid beta-glucosidase;D-glucosyl-N-acylsphingosine glucohydrolase;Beta-glucocerebrosidase(Beta-GC);Imiglucerase;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with saposin-C.
    Function:
    N/A
    Subcellular Location:
    Lysosome membrane Peripheral membrane protein Lumenal side Interaction with saposin-C promotes membrane association.
    Protein Attributes:
    Sequence length:
    536
    Sequence:
    50:
    MEFSSPSREE | CPKPLSRVSI | MAGSLTGLLL | LQAVSWASGA | RPCIPKSFGY | 
    100:
    SSVVCVCNAT | YCDSFDPPTF | PALGTFSRYE | STRSGRRMEL | SMGPIQANHT | 
    150:
    GTGLLLTLQP | EQKFQKVKGF | GGAMTDAAAL | NILALSPPAQ | NLLLKSYFSE | 
    200:
    EGIGYNIIRV | PMASCDFSIR | TYTYADTPDD | FQLHNFSLPE | EDTKLKIPLI | 
    250:
    HRALQLAQRP | VSLLASPWTS | PTWLKTNGAV | NGKGSLKGQP | GDIYHQTWAR | 
    300:
    YFVKFLDAYA | EHKLQFWAVT | AENEPSAGLL | SGYPFQCLGF | TPEHQRDFIA | 
    350:
    RDLGPTLANS | THHNVRLLML | DDQRLLLPHW | AKVVLTDPEA | AKYVHGIAVH | 
    400:
    WYLDFLAPAK | ATLGETHRLF | PNTMLFASEA | CVGSKFWEQS | VRLGSWDRGM | 
    450:
    QYSHSIITNL | LYHVVGWTDW | NLALNPEGGP | NWVRNFVDSP | IIVDITKDTF | 
    500:
    YKQPMFYHLG | HFSKFIPEGS | QRVGLVASQK | NDLDAVALMH | PDGSAVVVVL | 
    536:
    NRSSKDVPLT | IKDPAVGFLE | TISPGYSIHT | YLWRRQ
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    UniGene:
    SMR:
    KEGG:
    String:
    MIM:
    Pfam:
    Uniprot:
     
    FOR
    ELISA Kit for Human Glucosylceramidase
    Cat.:
    E1448h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Glucosylceramidase
    Cat.:
    E1448m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human Glucosylceramidase
    Cat.:
    E1448b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    ELISA Kit for Human Glucosylceramidase
    Cat.:
    E1448p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Glucosylceramidase
    Cat.:
    U1448h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Glucosylceramidase
    Cat.:
    U1448p
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Glucosylceramidase
    Cat.:
    U1448b
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human Glucosylceramidase
    Cat.:
    U1448m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    Polyclonal Antibody for Human Glucosylceramidase
    Polyclonal Antibody for Human Glucosylceramidase
    Polyclonal Antibody for Human Glucosylceramidase
    Cat.:
    P1448Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human Glucosylceramidase
    Cat.:
    P1448Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human Glucosylceramidase
    Monoclonal Antibody for Human Glucosylceramidase
    Monoclonal Antibody for Human Glucosylceramidase
    Monoclonal Antibody for Human Glucosylceramidase
    Protein for Human Glucosylceramidase
    Protein for Human Glucosylceramidase
    Protein for Human Glucosylceramidase
    Protein for Human Glucosylceramidase

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA."
      Sorge J. , West C. , Westwood B. , Beutler E.
      Proc. Natl. Acad. Sci. U.S.A.82:7289-7293(1985) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT)
      tissue: Placenta.
    2. 2.
      "Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase."
      Tsuji S. , Choudary P.V. , Martin B.M. , Winfield S. , Barranger J.A. , Ginns E.I.
      J. Biol. Chem.261:50-53(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT);VARIANT LEU-298
      tissue: Hepatoma.
    3. 3.
      "The human glucocerebrosidase gene and pseudogene: structure and evolution."
      Horowitz M. , Wilder S. , Horowitz Z. , Reiner O. , Gelbart T. , Beutler E.
      Genomics4:87-96(1989) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
      tissue: Liver.
    4. 4.
      "Polymorphisms in the human glucocerebrosidase gene."
      Beutler E. , West C. , Gelbart T.
      Genomics12:795-800(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
      tissue: Liver.
    5. 5.
      "A novel transcript from a pseudogene for human glucocerebrosidase in non-Gaucher disease cells."
      Imai K. , Nakamura M. , Yamada M. , Asano A. , Yokoyama S. , Tsuji S. , Ginns E.I.
      Gene136:365-368(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND 3);VARIANTS GD ARG-223; GLY-230; PRO-235; ARG-241; ILE-252 AND ARG-364;VARIANTS GLY-310 AND HIS-368
    6. 6.
      "Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease."
      Winfield S.L. , Tayebi N. , Martin B.M. , Ginns E.I. , Sidransky E.
      Genome Res.7:1020-1026(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    7. 7.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS LONG; 4 AND 5);VARIANT MET-408
    8. 8.
      "The DNA sequence and biological annotation of human chromosome 1."
      Gregory S.G. , Barlow K.F. , McLay K.E. , Kaul R. , Swarbreck D. , Dunham A. , Scott C.E. , Howe K.L. , Woodfine K. , Spencer C.C.A. , Jones M.C. , Gillson C. , Searle S. , Zhou Y. , Kokocinski F. , McDonald L. , Evans R. , Phillips K. , more...
      Nature441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    9. 9.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG)
      tissue: Placenta.
    10. 10.
      "Structural analysis of the human glucocerebrosidase genes."
      Reiner O. , Wigderson M. , Horowitz M.
      DNA7:107-116(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-11
    11. 11.
      "The human glucocerebrosidase gene has two functional ATG initiator codons."
      Sorge J.A. , West C. , Kuhl W. , Treger L. , Beutler E.
      Am. J. Hum. Genet.41:1016-1024(1987) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-45
    12. 12.
      "Structural studies of human placental glucocerebrosidase."
      Martin B.M. , Murray G.J. , Coligan J.E. , Raum M. , Brady R.O. , Barranger J.A.
      Fed. Proc.43:1869-1869(1984)
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 40-44
      tissue: Placenta.
    13. 13.
      "Isolation of cDNA clones for human beta-glucocerebrosidase using the lambda gt11 expression system."
      Ginns E.I. , Choudary P.V. , Martin B.M. , Winfield S. , Stubblefield B. , Mayor J. , Merkle-Lehman D. , Murray G.J. , Bowers L.A. , Barranger J.A.
      Biochem. Biophys. Res. Commun.123:574-580(1984) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 403-416
    14. 14.
      "Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals."
      Tsuji S. , Martin B.M. , Barranger J.A. , Stubblefield B.K. , LaMarca M.E. , Ginns E.I.
      Proc. Natl. Acad. Sci. U.S.A.85:2349-2352(1988)
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 409-462;VARIANT GD1 SER-409
      tissue: Skin.
    15. 15.
      "Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site."
      Dinur T. , Osiecki K.M. , Legler G. , Gatt S. , Desnick R.J. , Grabowski G.A.
      Proc. Natl. Acad. Sci. U.S.A.83:1660-1664(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 469-520
      tissue: Placenta.
    16. 16.
      "Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry."
      Miao S. , McCarter J.D. , Grace M.E. , Grabowski G.A. , Aebersold R. , Withers S.G.
      J. Biol. Chem.269:10975-10978(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: MUTAGENESIS OF GLU-379;ACTIVE SITE;IDENTIFICATION BY MASS SPECTROMETRY
    17. 17.
      "Further studies on the reconstitution of glucosylceramidase activity by Sap C and anionic phospholipids."
      Salvioli R. , Tatti M. , Ciaffoni F. , Vaccaro A.M.
      FEBS Lett.472:17-21(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH SAPOSIN-C AND MEMBRANES CONTAINING ANIONIC PHOSPHOLIPIDS
    18. 18.
      "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry."
      Zhang H. , Li X.-J. , Martin D.B. , Aebersold R.
      Nat. Biotechnol.21:660-666(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-98; ASN-185 AND ASN-309
    19. 19.
      "LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase."
      Reczek D. , Schwake M. , Schroder J. , Hughes H. , Blanz J. , Jin X. , Brondyk W. , Van Patten S. , Edmunds T. , Saftig P.
      Cell131:770-783(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION;INTERACTION WITH SCARB2
    20. 20.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]
      tissue: Placenta.
    21. 21.
      "Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease."
      Neumann J. , Bras J. , Deas E. , O'Sullivan S.S. , Parkkinen L. , Lachmann R.H. , Li A. , Holton J. , Guerreiro R. , Paudel R. , Segarane B. , Singleton A. , Lees A. , Hardy J. , Houlden H. , Revesz T. , Wood N.W.
      Brain132:1783-1794(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT IN PARKINSON DISEASE;VARIANTS GLU-46; CYS-170; GLU-232; GLN-296; SER-409; ALA-419; HIS-448; ASN-482; PRO-483; PRO-495; LEU-497 AND CYS-502
    22. 22.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-98 AND ASN-309
      tissue: Liver.
    23. 23.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    24. 24.
      "X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease."
      Dvir H. , Harel M. , McCarthy A.A. , Toker L. , Silman I. , Futerman A.H. , Sussman J.L.
      EMBO Rep.4:704-709(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 40-536;GLYCOSYLATION AT ASN-58;DISULFIDE BONDS
    25. 25.
      "X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease."
      Premkumar L. , Sawkar A.R. , Boldin-Adamsky S. , Toker L. , Silman I. , Kelly J.W. , Futerman A.H. , Sussman J.L.
      J. Biol. Chem.280:23815-23819(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 40-536 IN COMPLEX WITH SYNTHETIC INHIBITOR;ACTIVE SITE
    26. 26.
      "Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations."
      Liou B. , Kazimierczuk A. , Zhang M. , Scott C.R. , Hegde R.S. , Grabowski G.A.
      J. Biol. Chem.281:4242-4253(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 40-536;CHARACTERIZATION OF VARIANTS GD SER-55; GLN-87; ASN-118; GLN-159; LEU-161; VAL-162; VAL-166; ASN-200; PHE-213; PHE-224; GLU-232; GLU-237; LEU-298; ILE-303; CYS-343; ILE-362; LYS-365; GLY-381; LYS-388; TRP-392; CYS-402; SER-409; VAL-410; HIS-419; LYS-421; ARG-429; LEU-433; SER-436; ASN-438; HIS-448; VAL-455; PRO-483; PRO-500 AND PRO-502;MUTAGENESIS OF CYS-43; CYS-57 AND CYS-62
    27. 27.
      "Structural comparison of differently glycosylated forms of acid-beta-glucosidase, the defective enzyme in Gaucher disease."
      Brumshtein B. , Wormald M.R. , Silman I. , Futerman A.H. , Sussman J.L.
      Acta Crystallogr. D62:1458-1465(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 40-536;GLYCOSYLATION AT ASN-58; ASN-98 AND ASN-185
    28. 28.
      "Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease."
      Lieberman R.L. , Wustman B.A. , Huertas P. , Powe A.C. Jr. , Pine C.W. , Khanna R. , Schlossmacher M.G. , Ringe D. , Petsko G.A.
      Nat. Chem. Biol.3:101-107(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 40-536 IN COMPLEXES WITH ISOFAGOMINE;SUBCELLULAR LOCATION
    29. 29.
      "Mutations causing Gaucher disease."
      Horowitz M. , Zimran A.
      Hum. Mutat.3:1-11(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON GD VARIANTS
    30. 30.
      "Glucocerebrosidase (Gaucher disease)."
      Beutler E. , Gelbart T.
      Hum. Mutat.8:207-213(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON GD VARIANTS
    31. 31.
      "Type 2 Gaucher disease: an expanding phenotype."
      Tayebi N. , Stone D.L. , Sidransky E.
      Mol. Genet. Metab.68:209-219(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON GD VARIANTS
    32. 32.
      "Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease."
      Stone D.L. , Tayebi N. , Orvisky E. , Stubblefield B. , Madike V. , Sidransky E.
      Hum. Mutat.15:181-188(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON GD VARIANTS
    33. 33.
      "Gaucher disease associated with a unique KpnI restriction site: identification of the amino-acid substitution."
      Beutler E. , Gelbart T.
      Ann. Hum. Genet.54:149-153(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD TYR-255
    34. 34.
      "Sequence of two alleles responsible for Gaucher disease."
      Hong C.M. , Ohashi T. , Yu X.J. , Weiler S. , Barranger J.A.
      DNA Cell Biol.9:233-241(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD
    35. 35.
      "Identification of six new Gaucher disease mutations."
      Beutler E. , Gelbart T. , West C.
      Genomics15:203-205(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD
    36. 36.
      "DNA analysis of an uncommon missense mutation in a Gaucher disease patient of Jewish-Polish-Russian descent."
      Choy F.Y.M. , Wei C. , Applegarth D.A. , McGillivray B.C.
      Am. J. Med. Genet.51:156-160(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD HIS-535
    37. 37.
      "Two new Gaucher disease mutations."
      Beutler E. , Gelbart T.
      Hum. Genet.93:209-210(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD ASN-438
    38. 38.
      "Y418C: a novel mutation in exon 9 of the glucocerebrosidase gene of a patient with Gaucher disease creates a new Bgl I site."
      Tuteja R. , Tuteja N. , Lilliu F. , Bembi B. , Galanello R. , Cao A. , Baralle F.E.
      Hum. Genet.94:314-315(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD SER-409 AND CYS-457
    39. 39.
      "Glucocerebrosidase mutations in Gaucher disease."
      Beutler E. , Demina A. , Gelbart T.
      Mol. Med.1:82-92(1994) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD ASP-215; THR-221; ARG-241; GLN-296; CYS-324; GLY-417 AND ASN-419
    40. 40.
      "Gaucher disease in Spanish patients: analysis of eight mutations."
      Cormand B. , Vilageliu L. , Burguera J.M. , Balcells S. , Gonzalez-Duarte R. , Grinberg D. , Chabas A.
      Hum. Mutat.5:303-309(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD SER-409; HIS-448; PRO-483 AND CYS-502
    41. 41.
      "Identification of a new mutation (P178S) in an African-American patient with type 2 Gaucher disease."
      Choy F.Y.M. , Wei C.
      Hum. Mutat.5:345-347(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD SER-217
    42. 42.
      "The molecular characterization of Gaucher disease in South Africa."
      Morar B. , Lane A.B.
      Clin. Genet.50:78-84(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD SER-409; LEU-426; LEU-433 AND PRO-483
    43. 43.
      "Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populations."
      Kim J.-W. , Liou B.B. , Lai M.-Y. , Ponce E. , Grabowski G.A.
      Hum. Mutat.7:214-218(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD LEU-54; GLU-85 AND SER-227
    44. 44.
      "Two novel (1098insA and Y313H) and one rare (R359Q) mutations detected in exon 8 of the beta-glucocerebrosidase gene in Gaucher's disease patients."
      Cormand B. , Vilageliu L. , Balcells S. , Gonzalez-Duatre R. , Chabas A. , Grinberg D.
      Hum. Mutat.7:272-274(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD HIS-352 AND GLN-398
    45. 45.
      "Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese."
      Amaral O. , Pinto E. , Fortuna M. , Lacerda L. , Sa Miranda M.C.
      Hum. Mutat.8:280-281(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD1 THR-435
    46. 46.
      "Two new missense mutations in a non-Jewish Caucasian family with type 3 Gaucher disease."
      Seeman P.J.V. , Finckh U. , Hoeppner J. , Lakner V. , Liebisch I. , Grau G. , Rolfs A.
      Neurology46:1102-1107(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD3 LEU-437 AND ILE-530
    47. 47.
      "Two new mild homozygous mutations in Gaucher disease patients: clinical signs and biochemical analyses."
      Cormand B. , Grinberg D. , Gort L. , Fiumara A. , Barone R. , Vilageliu L. , Chabas A.
      Am. J. Med. Genet.70:437-443(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD LEU-414 AND THR-441
    48. 48.
      "Identification of two novel and four uncommon missense mutations among Chinese Gaucher disease patients."
      Choy F.Y.M. , Humphries M.L. , Shi H.
      Am. J. Med. Genet.71:172-178(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD VAL-76; GLU-85; TRP-87; TRP-159; SER-227; ILE-252 AND PRO-483
    49. 49.
      "Mutation analysis in 46 British and Irish patients with Gaucher's disease."
      Hatton C.E. , Cooper A. , Whitehouse C. , Wraith J.E.
      Arch. Dis. Child.77:17-22(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD LYS-501
    50. 50.
      "Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients."
      Grace M.E. , Desnick R.J. , Pastores G.M.
      J. Clin. Invest.99:2530-2537(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD TRP-87; GLU-234; ARG-241; ILE-252; ASN-310; LEU-391 AND SER-409
    51. 51.
      "Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations."
      Ida H. , Rennert O.M. , Kawame H. , Maekawa K. , Eto Y.
      J. Inherit. Metab. Dis.20:67-73(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD VAL-228; ILE-252; GLY-405; HIS-448; GLN-452; PRO-483 AND CYS-535
    52. 52.
      "D409H/D409H genotype in Gaucher-like disease."
      Uyama E. , Uchino M. , Ida H. , Eto Y. , Owada M.
      J. Med. Genet.34:175-175(1997) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT PSEUDO-GAUCHER HIS-448
    53. 53.
      "Six new Gaucher disease mutations."
      Demina A. , Beutler E.
      Acta Haematol.99:80-82(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD LEU-146; LEU-198; THR-380; ASN-405 AND ARG-432
    54. 54.
      "Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease."
      Germain D.P. , Puech J.-P. , Caillaud C. , Kahn A. , Poenaru L.
      Am. J. Hum. Genet.63:415-427(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD
    55. 55.
      "Gaucher type 2 disease: identification of a novel transversion mutation in a French-Irish patient."
      Choy F.Y.M. , Humphries M.L. , Ben-Yoseph Y.
      Am. J. Med. Genet.78:92-93(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD2 TYR-513
    56. 56.
      "Hematologically important mutations: Gaucher disease."
      Beutler E. , Gelbart T.
      Blood Cells Mol. Dis.24:2-8(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD
    57. 57.
      "A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease."
      Sinclair G. , Choy F.Y.M. , Humphries L.
      Blood Cells Mol. Dis.24:420-427(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD2 LYS-80; CYS-170 AND PRO-483
    58. 58.
      "A novel mutation of the beta-glucocerebrosidase gene associated with neurologic manifestations in three sibs."
      Parenti G. , Filocamo M. , Titomanlio L. , Rizzolo G. , Silvestro E. , Perretti A. , Gatti R. , Andria G.
      Clin. Genet.53:281-285(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD GLY-392
    59. 59.
      "Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome."
      Cormand B. , Grinberg D. , Gort L. , Chabas A. , Vilageliu L.
      Hum. Mutat.11:295-305(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD GLU-152; PRO-173; GLU-428; LEU-430; ILE-431 AND HIS-451
    60. 60.
      "A novel mutation (V191G) in a German-British type 1 Gaucher disease patient."
      Choy F.Y.M. , Humphries M.L. , Ben-Yoseph Y.
      Hum. Mutat.11:411-412(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD1 GLY-230 AND SER-409
    61. 61.
      "Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation."
      Wasserstein M.P. , Martignetti J.A. , Zeitlin R. , Lumerman H. , Solomon M. , Grace M.E. , Desnick R.J.
      Am. J. Med. Genet.84:334-339(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD1 SER-409 AND LEU-440
    62. 62.
      "Glucocerebrosidase mutations among Chinese neuronopathic and non-neuronopathic Gaucher disease patients."
      Choy F.Y.M. , Wong K. , Shi H.P.
      Am. J. Med. Genet.84:484-486(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD ARG-241; CYS-244; ILE-252; HIS-448 AND PRO-483
    63. 63.
      "Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles."
      Hodanov K. , Hrebicek M. , Cervenkov M. , Mrzov L. , Veprekov L. , Zemen J.
      Blood Cells Mol. Dis.25:287-298(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD
    64. 64.
      "Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?"
      Stone D.L. , van Diggelen O.P. , de Klerk J.B.C. , Gaillard J.L.J. , Niermeijer M.F. , Willemsen R. , Tayebi N. , Sidransky E.
      Eur. J. Hum. Genet.7:505-509(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS PERINATAL LETHAL GD ARG-350 AND PHE-437
    65. 65.
      "Detection of three rare (G377S, T134P and 1451delAC), and two novel mutations (G195W and Rec[1263del55;1342G>C]] in Spanish Gaucher disease patients."
      Sarria A.J. , Giraldo P. , Perez-Calvo J.I. , Pocovi M.
      Hum. Mutat.14:88-88(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD PRO-173; TRP-234; SER-409; SER-416; HIS-448 AND PRO-483
    66. 66.
      "Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease."
      Koprivica V. , Stone D.L. , Park J.K. , Callahan M. , Frisch A. , Cohen I.J. , Tayebi N. , Sidransky E.
      Am. J. Hum. Genet.66:1777-1786(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD TRP-87; ASN-118; THR-129; ASP-156; GLN-159; TRP-159; LEU-170; ILE-173; CYS-209; PRO-209; SER-227; THR-229; PRO-235; ARG-241; ILE-252; GLN-296; CYS-324; THR-380; MET-408; SER-409; SER-416; LEU-433; TYR-438; HIS-448; PRO-483 AND CYS-502;VARIANT LYS-365
    67. 67.
      "Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S)."
      Bodamer O.A.F. , Church H.J. , Cooper A. , Wraith J.E. , Scott C.R. , Scaglia F.
      Am. J. Med. Genet.109:328-331(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD SER-55 AND HIS-448
    68. 68.
      "The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease."
      Orvisky E. , Park J.K. , Parker A. , Walker J.M. , Martin B.M. , Stubblefield B.K. , Uyama E. , Tayebi N. , Sidransky E.
      Hum. Mutat.19:458-459(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD GLU-175; PRO-201; GLU-237; LEU-290 AND PHE-441
    69. 69.
      "Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients."
      Filocamo M. , Mazzotti R. , Stroppiano M. , Seri M. , Giona F. , Parenti G. , Regis S. , Corsolini F. , Zoboli S. , Gatti R.
      Hum. Mutat.20:234-235(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD THR-198; ARG-241; ARG-270; ILE-400 AND ARG-490
    70. 70.
      "Gaucher's disease with Parkinson's disease: clinical and pathological aspects."
      Bembi B. , Zambito Marsala S. , Sidransky E. , Ciana G. , Carrozzi M. , Zorzon M. , Martini C. , Gioulis M. , Pittis M.G. , Capus L.
      Neurology61:99-101(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: POSSIBLE INVOLVEMENT IN PARKINSON DISEASE
    71. 71.
      "Homozygous loss of a cysteine residue in the glucocerebrosidase gene results in Gaucher's disease with a hydropic phenotype."
      Church H.J. , Cooper A. , Stewart F. , Thornton C.M. , Wraith J.E.
      Eur. J. Hum. Genet.12:975-978(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT GD SER-55
    72. 72.
      "The N370S (Asn370->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C."
      Salvioli R. , Tatti M. , Scarpa S. , Moavero S.M. , Ciaffoni F. , Felicetti F. , Kaneski C.R. , Brady R.O. , Vaccaro A.M.
      Biochem. J.390:95-103(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: CHARACTERIZATION OF VARIANT GD SER-409
    73. 73.
      "Identification and functional characterization of five novel mutant alleles in 58 Italian patients with Gaucher disease type 1."
      Miocic S. , Filocamo M. , Dominissini S. , Montalvo A.L. , Vlahovicek K. , Deganuto M. , Mazzotti R. , Cariati R. , Bembi B. , Pittis M.G.
      Hum. Mutat.25:100-100(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS GD1 ASN-63; SER-158; TRP-159; CYS-170; LEU-221; GLU-230; ARG-241; GLN-294; CYS-324; SER-409; ASN-438; LEU-440; HIS-448; CYS-457; ASP-460; PRO-483 AND ARG-490;CHARACTERIZATION OF VARIANTS GD1 ASN-63; SER-158; LEU-221; GLU-230 AND ASP-460
    74. 74.
      "Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation."
      Aharon-Peretz J. , Badarny S. , Rosenbaum H. , Gershoni-Baruch R.
      Neurology65:1460-1461(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: POSSIBLE INVOLVEMENT IN PARKINSON DISEASE
    75. 75.
      "Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients."
      Tan E.K. , Tong J. , Fook-Chong S. , Yih Y. , Wong M.C. , Pavanni R. , Zhao Y.
      Arch. Neurol.64:1056-1058(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT OF VARIANT GD PRO-483 IN SUSCEPTIBILITY TO PARKINSON DISEASE
    76. 76.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INVOLVEMENT OF VARIANTS GD SER-409 AND PRO-483 IN SUSCEPTIBILITY TO PARKINSON DISEASE
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter